Syringe
Latest Bio-Technology General Corp. Patents:
- Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
- Use of oxandrolone in the treatment of burns an other wounds
- Use of oxandrolone in the treatment of burns and other wounds
- Human manganese superoxide dismutase DNA, its expression and method of recovering human manganese superoxide dismutase
- Polypeptide having factor Xa inhibitory activity
Description
FIG. 1 is a photograph showing the bottom plan view of a syringe embodying our new design;
FIG. 2 is a photograph showing a front elevational view of a syringe embodying our new design;
FIG. 3 is a photograph showing a back elevational view of a syringe embodying our new design;
FIG. 4 is a photograph showing the elevational view of one side of a syringe embodying our new design. The sides of the syringe embodying our new design are symmetrical; and,
FIG. 5 is a photograph showing the top plan view of a syringe embodying our new design.
Referenced Cited
Patent History
Patent number: D403064
Type: Grant
Filed: Jun 28, 1995
Date of Patent: Dec 22, 1998
Assignee: Bio-Technology General Corp. (Iselin, NJ)
Inventors: Yehuda Einav (Holon), Dror Eyal (Rehovot)
Primary Examiner: Louis S. Zarfas
Assistant Examiner: Frank Martinez
Attorney: John P. White
Application Number: 0/40,830
Type: Grant
Filed: Jun 28, 1995
Date of Patent: Dec 22, 1998
Assignee: Bio-Technology General Corp. (Iselin, NJ)
Inventors: Yehuda Einav (Holon), Dror Eyal (Rehovot)
Primary Examiner: Louis S. Zarfas
Assistant Examiner: Frank Martinez
Attorney: John P. White
Application Number: 0/40,830
Classifications
Current U.S. Class:
Rectilinear Arrangement Of Actuator And Plunger (i.e., Straight-line Syringe Type) (D24/114)
International Classification: 2402;
International Classification: 2402;